Observational Study of Effects of Saroglitazar on Glycaemic and Lipid Parameters on Indian Patients with Type 2 Diabetes

Cardiovascular risk reduction is an important issue in the management of patients with Type 2 diabetes mellitus. Peroxisome proliferator activated receptor (PPAR) agonists favourably influence glycaemic and lipid parameters in patients with Type 2 diabetes and a dual PPAR agonist is expected to have...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Sanjay, Majumder, Anirban, Ray, Subir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287720/
https://www.ncbi.nlm.nih.gov/pubmed/25573251
http://dx.doi.org/10.1038/srep07706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287720/
https://www.ncbi.nlm.nih.gov/pubmed/25573251
http://dx.doi.org/10.1038/srep07706

Ejemplares similares